Get the free weekly executive digest
The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New leadership moves, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Amphista Therapeutics Appoints Antony Mattessich As Chief Executive Officer
Position
Chief Executive Officer
Company
Amphista Therapeutics
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Amphista Therapeutics announces the appointment of Antony Mattessich as its Chief Executive Officer, contributing to the acceleration of the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein degraders into the clinic and building a robust pipeline. Antony Mattessich, an experienced CEO, brings an impressive track record progressing programs from discovery, through clinical development and commercial success, with extensive experience in CNS, haemato-oncology, immunology, and metabolics.